The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 336:441-442 February 6, 1997 Number 6
NextNext

Anticoagulation for Nonrheumatic Atrial Fibrillation

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-Related Article
 by Hylek, E. M.
-PubMed Citation
To the Editor: Hylek et al. (Aug. 22 issue)1 imply that the lowest effective intensity of anticoagulation for patients with nonvalvular atrial fibrillation is an international normalized ratio (INR) >2.0. Although this intensity may be optimal to prevent ischemic stroke, it would be useful to establish whether an INR of 1.6 to 1.9 offers substantial protection, a point that is potentially important for patients at particular risk of bleeding during anticoagulant therapy.2 If I interpret their data correctly, an INR of 1.6 to 1.9 was associated with a reduction of 75 percent or more in the risk of stroke, as . . . [Full Text of this Article]

References




HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.